Fundacja Wspierania Badań nad Ujawnianiem Wiedzy Starożytnej i Współczesnej Mądrość Narodów (KRS 0000474376, NIP 1132868492) is a Polish company, headquartered in Warszawa, Mazowieckie voivodeship. Fundacja Wspierania Badań nad Ujawnianiem Wiedzy Starożytnej i Współczesnej Mądrość Narodów operates in: Research and experimental development on social sciences and humanities (PKD 72.20.Z). Industry: Research and development. The company has been listed in the National Court Register since August 26, 2013. Fundacja Wspierania Badań nad Ujawnianiem Wiedzy Starożytnej i Współczesnej Mądrość Narodów's most recently reported net revenue was 127.8 K PLN for 2025.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Business profile - Fundacja Wspierania Badań nad Ujawnianiem Wiedzy Starożytnej i Współczesnej Mądrość Narodów
Identity
- Name
- Fundacja Wspierania Badań nad Ujawnianiem Wiedzy Starożytnej i Współczesnej Mądrość Narodów
- Legal form
- FUNDACJA
- Founded
- August 26, 2013
- Registry status as of
- July 14, 2026
- Latest entry
- July 14, 2026
- Founding act
- 02.07.2013 R. 07.08.2013 R. ZMIANA § 2, § 9, § 13, § 17, § 18, § 20, § 21 I PRZYJĘCIE TEKSTU JEDNOLITEGO STATUTU.
Articles of association history (3)
- July 2, 2013: 02.07.2013 R. 07.08.2013 R. ZMIANA § 2, § 9, § 13, § 17, § 18, § 20, § 21 I PRZYJĘCIE TEKSTU JEDNOLITEGO STATUTU.
- December 22, 2014: STATUT ZMIENIONY UCHWAŁĄ RADY FUNDACJI NR 4/2014 Z DN. 22.12.2014R. ZMIENIONO: § 16 PKT 2
- February 24, 2022: STATUT ZMIENIONY UCHWAŁĄ NR 1/2022 RADY FUNDACJI Z DN. 24.02.2022 R. ZMIENIONO § 16 PKT 2. PO ZMIANACH § 16 PKT 2 STATUTU OTRZYMAŁ NOWE BRZMIENIE: "RADA LICZY OD TRZECH DO SZESNASTU CZŁONKÓW"
Activities
Other activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- BISKUPIA, 38, 6, 04-216, WARSZAWA, POLSKA
- Voivodeship
- MAZOWIECKIE
- District
- M.ST. WARSZAWA
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
Risk and payment profile - Fundacja Wspierania Badań nad Ujawnianiem Wiedzy Starożytnej i Współczesnej Mądrość Narodów
Credibility rating
74 / 100
Good credibility
Insolvency risk
Very low
Elevated threat
Closure risk
1
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organisational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/13 yrs
Board changes
4
4/13 yrs
PKD changes
1
1/13 yrs
Name changes
1
1/13 yrs
Data from 13 years of registry activity.
Credibility history
Payment reliability score from 2018–2025
Current: B (74/100)
Trend: stable (-1.1 pts/year)
High payment credibility - the company's financial condition is good and the risk of cooperating with it is low.
Trade credit limit history
Standard limit from 2018–2025
Current: 96.5 K PLN
Safe: 62.7 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Fundacja Wspierania Badań nad Ujawnianiem Wiedzy Starożytnej i Współczesnej Mądrość Narodów
Founded
August 26, 2013
12 years in operation
Legal form
FUNDACJA
Registry: RejP
Headquarters
WARSZAWA
MAZOWIECKIE
Primary PKD
72.20.Z
Research and experimental development on social sciences and humani…
Share capital
N/A
Shareholders
N/A
Board
3 people
Sup. board: 13
Filed years
8 years
2018–2025 · profitable: 7/8
Registry entries
41
latest: July 14, 2026
Revenue
127.8 K PLN
2025
Net profit
50.5 K PLN
2025
Assets
284.4 K PLN
2025
Equity
256.4 K PLN
2025
EBITDA
N/A
2025
no depreciation data
Valuation
267.0 K PLN
Medium confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Fundacja Wspierania Badań nad Ujawnianiem Wiedzy Starożytnej i Współczesnej Mądrość Narodów.
No ratings
Related articles
News
Bioceltix in the final EMA dialogue phase: BCX-CM-J could become Europe's first veterinary cell-therapy drug for dogs
Wrocław-based Bioceltix S.A. (KRS 0000744521) entered Q2 2026 in the final EMA dialogue phase on BCX-CM-J – potentially Europe's first veterinary cell-therapy drug based on mesenchymal stem cells, for dogs with osteoarthritis. Responses to the EMA's final questions are due in May 2026; a CVMP recommendation and marketing authorisation are possible in Q3/Q4 2026. A pre-commercial biotech: it closed 2024 with a PLN 14.9m loss on zero revenue and PLN 33.6m of cash at year-end. Trigon DM maintains a buy rating with a PLN 127.2 price target.
News
Captor Therapeutics: PLN 36m of cash at 30 September 2025, runway to mid-2026 – clinical data versus the cash clock
Wrocław-based Captor Therapeutics S.A. (KRS 0000756383) – a pre-commercial biotech specialising in targeted protein degradation (TPD) – closed Q3 2025 with PLN 36m of cash and grants securing funding to mid-2026. CT-01 (hepatocellular carcinoma) entered Phase I, with the first patient dosed at the Barcelona Clinic Liver Cancer. CT-03, an MCL-1 degrader, is close to clinical entry. Without a new R&D partnership or share issue in 2026, the company will need additional financing.
